Marios Dimitriou

Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomics

C. Langenberg, H. Schiöth, M. Johansson, 2023, medRxiv.

Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers.

T. Assimes, A. Butterworth, M. Johansson, 2024, Nature communications.

Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics

H. Schiöth, M. Johansson, R. Travis, 2024, EBioMedicine.

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation

I. Dybedal, E. Ejerblad, M. Jädersten, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.